Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Skeletal Muscle Relaxants: Adverse Effects01:21

Skeletal Muscle Relaxants: Adverse Effects

1.1K
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
1.1K
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

873
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
873
Sedatives and Hypnotics Drugs: Benzodiazepines01:19

Sedatives and Hypnotics Drugs: Benzodiazepines

1.3K
Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
1.3K
Sedatives and Hypnotics: Overview01:23

Sedatives and Hypnotics: Overview

2.1K
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
2.1K
Anxiolytic Drugs: Benzodiazepines and Buspirone01:29

Anxiolytic Drugs: Benzodiazepines and Buspirone

3.1K
Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...
3.1K
Sedatives and Hypnotics Drugs: Barbiturates01:20

Sedatives and Hypnotics Drugs: Barbiturates

1.4K
Sedatives and hypnotics encompass a drug class that acts on the central nervous system (CNS) to alleviate anxiety, promote relaxation and induce sleep.These drugs function by amplifying the actions of the neurotransmitter γ-aminobutyric acid (GABA), resulting in reduced neuronal activity. Barbiturates, a subset of sedatives and hypnotics first synthesized in the late 1800s, are categorized into ultra-short, short, intermediate, and long-acting groups based on their duration of effect. A...
1.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chronic alcohol exposure during critical developmental periods differentially impacts persistence of deficits in cognitive flexibility and related circuitry.

International review of neurobiology·2021
Same author

Gilles de la Tourette syndrome in pregnancy: a retrospective series.

Obstetric medicine·2016
Same author

Corrections. A personal 35 year perspective on Gilles de la Tourette syndrome: prevalence, phenomenology, comorbidities, and coexistent psychopathologies.

The lancet. Psychiatry·2015
Same author

Corrections. A personal 35 year perspective on Gilles de la Tourette syndrome: assessment, investigations, and management.

The lancet. Psychiatry·2015
Same author

γ-Hydroxybutyrate (GHB) - Effects on Human Performance and Behavior.

Forensic science review·2015
Same author

Gilles de la Tourette syndrome in a cohort of deaf people.

Asian journal of psychiatry·2015
Same journal

Breath-alcohol analysis as a surrogate for blood-alcohol concentration depends on assuming a constant blood/breath ratio of alcohol.

Forensic science review·2025
Same journal

Driving under the influence of drugs: An overview of current legal frameworks.

Forensic science review·2025
Same journal

Forensic importance and advancements in microscopic examination of questioned documents.

Forensic science review·2025
Same journal

Fingerprints in ancient China - A mini-review.

Forensic science review·2025
Same journal

Development and present status of impaired driving legislation in the United Kingdom.

Forensic science review·2025
Same journal

Scotch Whiskies and Forensic Examinations of Manufacturing-Derived Features for Their Authentication.

Forensic science review·2024
See all related articles

Related Experiment Video

Updated: Apr 5, 2026

Author Spotlight: Combined Peripheral Nerve Stimulation and Controllable Pulse Parameter Transcranial Magnetic Stimulation to Probe Sensorimotor Control and Learning
14:47

Author Spotlight: Combined Peripheral Nerve Stimulation and Controllable Pulse Parameter Transcranial Magnetic Stimulation to Probe Sensorimotor Control and Learning

Published on: April 21, 2023

3.9K

Carisoprodol - Effects on Human Performance and Behavior.

M M Robertson1, L J Marinetti2

  • 1Independent Forensic Consulting, Beaumaris, Victoria, Australia.

Forensic Science Review
|August 11, 2015
PubMed
Summary
This summary is machine-generated.

Carisoprodol, a muscle relaxant, impairs driving ability due to its sedating effects. Its role in car accidents may be underestimated because of co-administered drugs and lack of routine testing.

Keywords:
Behaviorcarisoprodoldrivinghuman performanceimpairmentmeprobamate

More Related Videos

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
07:02

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development

Published on: February 11, 2019

10.4K
Paw-Print Analysis of Contrast-Enhanced Recordings PrAnCER: A Low-Cost, Open-Access Automated Gait Analysis System for Assessing Motor Deficits
06:25

Paw-Print Analysis of Contrast-Enhanced Recordings PrAnCER: A Low-Cost, Open-Access Automated Gait Analysis System for Assessing Motor Deficits

Published on: August 12, 2019

9.2K

Related Experiment Videos

Last Updated: Apr 5, 2026

Author Spotlight: Combined Peripheral Nerve Stimulation and Controllable Pulse Parameter Transcranial Magnetic Stimulation to Probe Sensorimotor Control and Learning
14:47

Author Spotlight: Combined Peripheral Nerve Stimulation and Controllable Pulse Parameter Transcranial Magnetic Stimulation to Probe Sensorimotor Control and Learning

Published on: April 21, 2023

3.9K
A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
07:02

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development

Published on: February 11, 2019

10.4K
Paw-Print Analysis of Contrast-Enhanced Recordings PrAnCER: A Low-Cost, Open-Access Automated Gait Analysis System for Assessing Motor Deficits
06:25

Paw-Print Analysis of Contrast-Enhanced Recordings PrAnCER: A Low-Cost, Open-Access Automated Gait Analysis System for Assessing Motor Deficits

Published on: August 12, 2019

9.2K

Area of Science:

  • Pharmacology
  • Forensic Toxicology
  • Road Safety

Background:

  • Carisoprodol is a widely prescribed muscle relaxant.
  • It causes central nervous system (CNS) depression, similar to benzodiazepines and alcohol.
  • Impaired driving is a significant public safety concern.

Purpose of the Study:

  • To highlight the adverse effects of carisoprodol and its metabolite meprobamate on human performance.
  • To emphasize the potential underestimation of carisoprodol's role in driver impairment and accidents.
  • To underscore the need for increased awareness and testing for carisoprodol in impaired driving cases.

Main Methods:

  • Review of existing literature on carisoprodol's pharmacological effects.
  • Analysis of documented symptoms associated with carisoprodol and meprobamate ingestion.
  • Discussion of challenges in assessing drug impairment in driving scenarios.

Main Results:

  • Carisoprodol and meprobamate induce CNS depressant effects, leading to drowsiness, confusion, and impaired balance/coordination.
  • These effects significantly degrade driving ability.
  • The full extent of carisoprodol's contribution to motor vehicle accidents is likely underestimated.

Conclusions:

  • Carisoprodol poses a risk to driving safety due to its performance-impairing effects.
  • Co-administration with other CNS depressants and lack of routine toxicological screening obscure carisoprodol's involvement in accidents.
  • Further research and improved testing protocols are needed to accurately assess carisoprodol's impact on road safety.